University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Mitomycin C Trabeculectomy Trial for Glaucoma in Ethiopia

Not Applicable

Withdrawn

Conditions: Glaucoma

Interventions: Drug: Mitomycin-C (MMC)

First Posted Date: 2016-04-20

Last Posted Date: 2023-08-01

Lead Sponsor: University of California, San Francisco

Registration Number: NCT02744690

Locations: 🇪🇹
Menelik II Hospital, Addis Ababa, Ethiopia

PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer

Not Applicable

Active, not recruiting

Conditions: Advanced Renal Cell Carcinoma
Genitourinary Cancer
Prostate Cancer
Advanced Urothelial Carcinoma

Interventions: Other: Systemic therapy
Device: StrataNGS

First Posted Date: 2016-04-12

Last Posted Date: 2024-12-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 156

Registration Number: NCT02735252

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers

Phase 3

Completed

Conditions: Fungal Keratitis
Corneal Ulcer

Interventions: Drug: Intrastromal voriconazole
Drug: Natamycin

First Posted Date: 2016-04-07

Last Posted Date: 2019-10-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 70

Registration Number: NCT02731638

Locations: 🇮🇳
Aravind Eye Hospitals, Pondicherry, Tamil Nadu, India
🇺🇸
Francis I. Proctor Foundation at UCSF, San Francisco, California, United States

Paired Integrative Exercise Program for People With Dementia and Caregivers

Not Applicable

Completed

Conditions: Dementia

Interventions: Behavioral: Paired PLIÉ Program

First Posted Date: 2016-04-06

Last Posted Date: 2025-01-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT02729311

Locations: 🇺🇸
Kaiser Oakland, Oakland, California, United States

Cryoanalgesia vs. Epidural in the Nuss Procedure

Phase 4

Completed

Conditions: Pectus Excavatum
Funnel Chest

Interventions: Device: Cryoanalgesia
Drug: Thoracic epidural (ropivicaine, fentanyl)

First Posted Date: 2016-03-28

Last Posted Date: 2021-05-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT02721017

Locations: 🇺🇸
UCSF-Benioff Children's Hospital, San Francisco, California, United States

THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease

Not Applicable

Completed

Conditions: Claudication, Intermittent
Vascular Occlusion
Vascular Diseases
Osteoarthritis
Peripheral Arterial Disease
Claudication
Vascular Calcification

Interventions: Dietary Supplement: SPM Emulsion, Dose-modality
Dietary Supplement: SPM Softgel, Dose-Modality
Dietary Supplement: Placebo Softgel

First Posted Date: 2016-03-25

Last Posted Date: 2021-05-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT02719665

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis

Phase 2

Completed

Conditions: Menopause
Multiple Sclerosis

Interventions: Drug: Tissue Selective Estrogen Complex
Drug: Placebo

First Posted Date: 2016-03-16

Last Posted Date: 2020-07-15

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 24

Registration Number: NCT02710214

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Trial of Proactive Community Case Management to Reduce Child Mortality

Not Applicable

Completed

Conditions: Under-five Child Mortality
Access to Health Care

Interventions: Other: Integrated Community Case Management
Other: Proactive Community Case Management
Other: Removal of point-of-care user fees
Other: Infrastructure improvements at primary health centre
Other: Training of primary health centre staff

First Posted Date: 2016-02-29

Last Posted Date: 2023-06-12

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 135149

Registration Number: NCT02694055

A Mindfulness Mobile Intervention Targeting Reductions in Food Cravings

Not Applicable

Completed

Conditions: Food Cravings

First Posted Date: 2016-02-29

Last Posted Date: 2017-05-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 104

Registration Number: NCT02694731

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD

Phase 2

Completed

Conditions: Age-Related Macular Degeneration
Dry Macular Degeneration
Geographic Atrophy
Macular Degeneration, Age-Related

Interventions: Drug: Metformin

First Posted Date: 2016-02-18

Last Posted Date: 2023-06-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 66

Registration Number: NCT02684578

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
University of California, Davis, Davis, California, United States
🇺🇸
Palo Alto Veteran Affairs Medical Center, Palo Alto, California, United States

and more 9 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy